Among 91 patients with HER-2-negative advanced or relapsed breast cancer, including 2 men and 89 women, 8 were diagnosed with pathogenic or likely pathogenic variants: BRCA1 (n = 4) and BRCA2 (n = 4) (Table 1). This evidence concerns the gene ERBB2 and breast cancer.